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Membrane transport is known to be regulated by protein phosphorylation and by small GTPases of the rab family. Using specific antibodies, we 
have identified a 55 kDa phosphorylated protein which co-immunoprecipitated with the cytosolic forms of rab5 and other rab proteins. We 
demonstrate, on the basis of its mobility in two-dimensional electrophoresis gels and its immunological properties, that this protein is rab GDI 
(p55/GDI). We also found that, a minor fraction of p55/GDI is membrane associated, but, whilst also complexed with rab proteins. it is not 
phosphorylated. On the basis of these data we suggest that the cycling of rab proteins between membranes and cytosol is regulated by phospho- 
rylation of p55/GDI. 
Small GTP-binding protein; Rab5; Rab GDI; Membrane traffic 
1. INTRODUCTION 
Intracellular membrane traffic events are known to 
be regulated by small GTPases of the SEC4NPTllrab 
family and also by protein phosphorylation [l]. In this 
study we have investigated whether there is a point of 
convergence between these two regulatory mechanisms, 
by looking for interactions between phosphorylated 
proteins and rab proteins. 
More specifically we have studied the small GTP- 
binding protein rab5, which localizes to early en- 
dosomes and the plasma membrane [2], and has been 
shown to regulate both fusion between early endosomes 
in vitro [3] and early endocytic events in vivo [4]. Since 
early endosome fusion is also regulated by phosphoryl- 
ation/dephosphorylation events, in both mitosis and in- 
terphase [5-71, we investigated the association of 
phosphorylated proteins with the rab5 protein. For 
these experiments we have used antibodies raised 
against the hypervariable carboxyl-terminal domain of 
the rab5 protein; antibodies raised against this domain 
are highly specific and have been extensively used in 
localisation studies [2,8,9]. 
By analogy with the related p21 ras proto-oncogene 
and by fluorescence spectroscopic measurements (M.J. 
Clague, unpublished observations), rab proteins un- 
dergo a conformational change upon hydrolysis of 
GTP. This molecular switching mechanism can be used 
to impart directionality, and specificity, to the process 
that they control [lo]. Small GTP-binding proteins are 
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post-nuclear supernatant. 
regulated by interactions with other proteins which con- 
trol the rate of this switching; proteins which inhibit 
GDP dissociation (GDI), facilitate nucleotide exchange 
(exchange factor), or enhance GTPase activity (GAP) 
of rab proteins have all been identified [l l-141. 
In this study we show that rab5, and other rab pro- 
teins, are associated with GDI both in cytosol and on 
membranes, and that in vivo the cytosolic GDI protein 
is phosphorylated when complexed to rabs. Previously 
GDI has been shown to associate with an array of rab 
proteins and to promote their dissociation from mem- 
branes [15-171. However, it was not clear how this asso- 
ciation could be regulated. Our results, together with an 
analysis of the membrane/cytosol distribution of the 
different forms, suggest that the cycling of rab proteins 
on and off membranes is regulated by GDI. We propose 
a simple model incorporating a universal role for GDI 
in specifying the directionality of this cycle. 
2. MATERIALS AND METHODS 
2.1. Cells and reagents 
BHK cells were maintained and seeded for experiments as described 
previously [18]. The polyclonal antibody against rab5 was raised 
against the C-terminal peptide according to the method described by 
Louvard et al. [19]. The polyclonal antibodies raised against C-termi- 
nal peptides of GDI and rab2 were kind gifts from Oliver Ullrich and 
Marino Zerial (EMBL. Heidelberg). The affinity purified antibodies 
against the C-terminal of rab4 were a kind gift from Peter van der 
Sluijs and Ira Mellman (Yale University School of Medicine, New 
Haven). The rab5 C-terminal (PKNEPQNPGANSARGR, [2]) and 
N-terminal (MANRGATRPNGPNTGNK) peptides were synthe- 
sized by Dominique Nalis (EMBL, Heidelberg). Guanosine [a-“Pltri- 
phosphate and [“P]orthophosphate were obtained from Amersham- 
Buchler, Germany. [%]methionine/cysteine (EXPRE%?S) was ob- 
tained from DuPont/NEN Research Products, Boston, MA. N- 
Octylpolyoxyethylene (Octyl-POE/Rosenbusch-Tenside) was ob- 
tained from Bachem-Biochemica GmbH, Heidelberg. 
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2 2 Metabok lab&g 
For metabolic labeling of phosphorylated proteins. 90% confluent 
cells (16 h after seeding) were taken and incubated for &6 h with 0.5 
mCi/ml of [“Plorthophosphate in phosphate-free Dulbeccos modified 
Eagles medium (DME). supplemented with 1% fetal calf serum (Gibco 
BRL, Germany) which had been dialyzed for 15 h against Tris-buff- 
ered sahne (TBS. 150 mM NaCl, 50 mM Tris-HCI, pH 7.4). For 
[“S]methionine/cysteme labeling. 40% confluent cells (4 h after seed- 
mg) were taken and incubated for 16 h m methiomne/cysteine free 
DME supplemented with 1% fetal calf serum and 0.2 mCi/ml 
EXPRE=S”S. 
2.3. Imnur2oprecipitatlon 
Post-nuclear supernatant (PNS) was prepared from BHK cells as 
described previously [18], except that TBS was used in place of phos- 
phate-buffered saline. Membrane and cytosol fractions were prepared 
by centrifuging PNS at 150,000 x g for 15 min in a Beckman TLIOO 
ultracentnfuge. and taking the pellet or supernatant. respectively. 
Membrane pellets were resuspended m homogemzation buffer (HB: 
3 mM imidazole. 250 mM sucrose, pH 7.4) before solubilisation, so 
that the protein concentration was equal to that of the cytosol. Sam- 
ples were then mixed with a 4-fold excess of Rosenbusch-Tenside 
buffer (RTB: 12.5 mM HEPES, 1.0 mM DTT, 0 5 mM EGTA. 100 
mM KOAc, 1 mM MgCl,, 1% n-octylpolyoxyethylene. pH 7.4) for 30 
min at 4°C Insoluble material was removed by centrifuging at 
150.000 x g. The supernatant (250 mg) was mlxed with antiserum (3 
ml) for 1 h at 4°C. In peptide competition experiments, peptide (720 
mg) was mixed with antiserum for 30 mm at 4°C and the mixture then 
added to the supernatant. Protein A-Sepharose beads (5 ml/ml of 
antiserum), which were preblocked with cold solubilized PNS when 
immunoprecipitating metabolically labeled proteins. were added and 
mixed for 30 mm at 4°C. The immune complexes were washed three 
times with RTB and three times with TBS Finally the immunoprecip- 
stated proteins were solubihzed m sample buffer (2% SDS. 100 mM 
DTT, 60 mM Tris, pH 6.8. 0 001% Bromophenol blue. 15% glycerol) 
and SDS-PAGE carried out. 
For immunoprecipitation of phosphorylated proteins all buffers 
were supplemented with 0.1 mM VOz- and IO mM KF. and the final 
concentration of MgClz was brought to IO mM immediately after 
homogenization. Solubihzed samples (60 mg protein) were added to 
antibodies (2 ml antiserum). which had been pre-coupled to Protein 
A-Sepharose beads (IO ml). and mixed at 4°C for one hour. When 
lmmunoprecipiating phosphorylated proteins from PNS a IO:1 vol- 
ume ratio of lmmunopreclpltation buffer (IB: 50 mM Tns. 150 mM 
KCI, 1% NP40. IO mM MgCl,, 0.1 mM VO,-. IO mM KF. pH 7.4) 
was added directly to the PNS and mixed for 30 min at J”C, IB was 
then also used, instead of RTB, for washing immunoprecipitates. 
Insoluble material was removed from “P-labeled samples by centri- 
fuging at high speed in a microfuge for 2 min. 
2.4. Elecrrophoresrs and [‘-‘P]GTP-ooerlq 
SDS-PAGE was carried out accorclmg to the system of Laemmh 
[20], using 12.5% gels. Labeled protems were visuahsed by fluorogra- 
phy; gels with “S-labeled proteins were treated with Enhance (NEN) 
and intenslfymg screens were used for “P-labeled proteins. Gels were 
exposed for 24 h to 1 week. For two-dimensional gel electrophoresis, 
samples were run on IEF tube gels, with a linear pH gradient between 
pH 4 5 and 7.4, and then on 15% acrylarmde second dimension resolv- 
ing gels as previously described 1211. 
GTP-overlay was as previously described [4]. Briefly. after SDS- 
PAGE. the gels were equilibrated in 20% glycerol, 50 mM Tris-HCI. 
pH 7.5 and the proteins then transfered to mtrocellulose at 50 mA for 
16 h (Transfer buffer: 3 mM Na?CO,, IO mM NaHCO,. pH 9.9). The 
mtrocellulose was then rinsed m binding buffer (BB: 50 mM 
NaH,PO,. IO mM MgC12. 2 mM DTT. 0.3% Tween 20. 4 mM ATP. 
pH 7 5) and incubated for 2 h with [a-“P]GTP (2 mCl/ml) in BB. The 
mtrocellulose was then washed extensively with BB. dried and exposed 






















Fig. 1. Rab proteins are complexed with a 55 kDa phosphorylated protein. (A) The Rab5 C-terminal antiserum is specific, as shown by [32P]GTP 
overlay after immunoprecipltation from membranes. Lane 1, rab5 antiserum; lane 2, rab5 antiserum with C-terminal rab5 peptide; lane 3, rab5 
antiserum with N-terminal rab5 peptide; lane 4, preimmune sera. (B) and (C) Immunoprecipitatlon from post-nuclear supernatants (PNS), prepared 
from [“Plorthophosphate labeled cells, with anti-rab antibodies. (B) lane 1, rab5 antiserum; lane 2. rab5 antiserum with C-terminal rab5 peptide. 
(C) lane 1, rab2 antiserum; lane 2. affimty purlfied rab4 anttbodies. Molecular weight markers are indicated. 
314 





30 B - 
RAB5 
GDI 
Fig. 2. 2D gel analysis of immunoprecipitates from cytosol of [“P]orthophosphate (a) and [%&ethionine (b and c) labeled BHK cells. (a) 
~mmunopre~ipitatjon with antibodies against rab5 (upper panel) or GDI (lower panel). (b) Immunopre~ipitation with antibodies agamst GDI. (c) 
Secttons of 2D gels, showing the area where GDI and its isoforms migrate, obtained after immunopr~ipitation with antibodies against rab5 (upper 
panel) or after longer exposure of the gel shown in (b, middle panel). The lower panel shows the pattern of total cytosohc proteins seen m the same 
area of our 2D gels. The major isofonn recognized by anti-GDI antibodies is indicated with an arrowhead and the other lsoforms indicated with 
small arrows. The large arrows mdicate major contaminants een in all of the gels. The apparent molecular weight of p55/GDI is higher on our 
2D gels (approx. 69 kDa) than on our 1D gels (approx. 55 kDa), we refer to it throughout his paper by its later apparent molecular weight. 
3. RESULTS AND DISCUSSION 
Fig. 1A shows that rab5 is specifically immunoprecip- 
itated from BHK extracts by our C-terminal antiserum, 
and that immune complex fo~ation is competed by the 
peptide against which the serum was raised. We then 
show that, when the same antiserum was used to im- 
munoprecipitate from PNS prepared from 32P-labelled 
cells, a phosphorylated protein of 55 kDa (~55) was 
specifically co-i~unoprecipitated, although rab5 itself 
was not detectably phosphorylated (Fig. 1B). By virtue 
of its mobility in 1D gels, we suspected that ~55 may be 
GDI. Since it has been proposed that essentially all 
cytosolic rab proteins are complexed to this protein 
[I 5,171, we tested antibodies specific for other rab pro- 
teins. Antibodies against rab2 and rab4 both im- 
munopre~ipitated phosphorylated pS5 (Fig. IB). Al- 
though rab4 co-localises with rab5 on endosomes [8], it 
is significant hat rab2 specifically localises to organelles 
of the early biosynthetic pathway [2,22]. 
Next we used high resoiution 2D gel electrophoresis 
to compare the physical characteristics of ~55 with 
those of GDI. Cytosol was prepared from 32P-labeled 
cells and immunoprecipitations carried out using either 
the anti-rab5 antibodies or an antibody raised against 
a peptide from the C-terminal region of GDI. Autoradi- 
ographs of the two immunopre~ipitates were then com- 
pared (Fig. 2a). The isoelectric focusing of ~55 indicates 
the existance of severai phosphorylation states (indi- 
cated by arrowheads in Fig. 2a and 2b), and, signifi- 
cantly, the anti-GDI antibody recognizes a protein with 
the same physical characteristics. Phosphoamino acid 
analysis, after acid hydrolysis of ~55, showed that serine 
residues were phospho~lated (not shown). 
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In order to investigate whether non-phosphorylated 
p55/GDI is also complexed with rab5 in cytosol, we 
repeated the immunoprecipitation experiments using 
cytosol prepared from cells metabolically-labeled with 
[?S]methionine/cysteine. After immunoprecipitation 
with the anti-GDI antibody, a single polypeptide was 
revealed in 21) gels, which must be an unphospho- 
rylated form of GDI, as its mobility is slightly more 
alkaline than any of the phosphorylated forms im- 
munoprecipitated by the same antibody (compare with 
Fig. 2a). Upon longer exposure of this gel the 
phosphorylated forms of GDI become evident (Fig. 2c, 
middle panel). In contrast the anti-rab5 and anti-rab4 
antibodies almost exclusively co-immunoprecipitated 
these phosphorylated forms of GDI (shown for rab5, 
Fig. 2c, upper panel). When we treated the 35S-labelled 
anti-rab5 immunoprecipitate with alkaline phosphatase 
prior to electrophoresis, these more acidic forms were 
shifted back to the position of unphosphorylated GDI 
(not shown). These experiments establish that cytosolic 
rab5, and other rab proteins, predominantly interact 
with the phosphorylated forms of cytosolic GDI. 
One surprising result of the above experiments was 
the observation that phosphorylated forms of p55fGDI 
were more effectively precipitated by anti-rab protein 
antibodies than by the anti-GDI antibody. In fact two- 
dimensional gel analysis of the complete cytosol (Fig. 
2c, bottom panel), shows that the phosphorylated forms 
of GDI are much more abundant than the unphospho- 
rylated form. We presume that the GDI antibody does 
not efficiently immunoprecipitate the phosphorylated 
GDI because the C-terminal epitope recognized by the 
antibody is masked by phosphorylation or by associa- 
tion with rab proteins. 
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Fig. 3. GDI is associated with GTP-binding proteins in cytosol and 
on membranes. (a) Immunoprecipitation of 35S-labeled proteins from 
cytosol or membranes by GDI antibodies. The position of GDI is 
indicated. (b) Visualization of small GTP-binding proteins by 
[32P]GTP overlay following immunoprecipitation with GDI antibodies 
from membranes and cytosol of unlabeled cells. Only the 18-30 kDa 
range is shown. 
When we repeated these immunoprecipitation experi- 
ments using membrane fractions in place of cytosol, we 
were unable to detect any phosphorylated p55/GDI 
(data not shown), although = 10% of the total im- 
munoprecipitable [35S]methionine/cysteine-labeled GDI 
is membrane associated (Fig. 3). In contrast, approxi- 
mately 80% of the rab5 protein is membrane associated 
[3]. We found that a significant fraction of the mem- 
brane associated form of GDI is complexed to rab pro- 
teins, as evidenced by [32P]GTP overlay of small GTP- 
binding proteins after co-immunoprecipitation with 
anti-GDI antibodies (Fig. 3). Altogether, our data con- 
firm that the cytosol contains a small proportion of rab 
proteins but the bulk of p55/GDI [3,17], and shows that 
these cytosolic rab proteins interact with a phospho- 
rylated form of GDI. In contrast the fraction of mem- 
brane associated rab proteins which are complexed with 
p55/GDI interact with its unphosphorylated form (Fig. 
4a). 
Since its discovery it has been apparent that GDI 
function must be regulated. The involvement of post- 
translational modifications has been postulated, but 
remained obscure [ 16,231. Phosphorylationl dephos- 
phorylation as reported here represents a strong candi- 
date for fulfilling this role and, in Fig. 4, we depict a 
simple scheme by which this mechanism may regulate 
the association of rab proteins with membranes. We 
propose that the specific association of rab proteins 
with membranes is initiated by interaction of the cy- 
tosolic, phosphorylated GDI-rab complex with a mem- 
brane associated protein, presumably a nucleotide ex- 
change factor. Exchange of GDP for GTP would pro- 
mote dissociation of the GDI-rab complex, due to the 
vastly reduced affinity of GDI for the GTP bound form 
of the rab protein [24], thus the lipoyl moiety of the rab 
protein would be freed to insert into the adjacent mem- 
brane. In this way the rab protein would be delivered 
to the membrane in its active conformation. Following 
GTP hydrolysis, the GDP-bound rab protein, by associ- 
ating with free GDI, would be extracted from the mem- 
brane. Phosphorylation of GDI would prevent reinser- 
tion of the rab protein into the membrane, except by 
interaction with the specific exchange factor. 
This model is consistent with properties of the 
unphosphorylated form of GDI reported by other 
groups; namely, inhibition of GDP dissociation and 
promotion of rab dissociation from the membrane 
[17,25]. Our model proposes that rab proteins are pre- 
sented to the appropriate membrane in a complex with 
GDI, this makes comprehensible a study by Araki et al. 
[24], who have shown that purified rab3a will non-spe- 
cifically associate with membranes (e.g. mitochondria, 
erythrocytes). A cycle of membrane association and dis- 
sociation is implicit in rab protein involvement in vecto- 
rial membrane transport [lo], and we predict that GDI 
will not be associated with membranes of vesicular in- 
termediates of membrane transport, but will be found 
on both donor and acceptor organelles. Although we 
have not so far localised the kinase and the phosphatase 
activities, we have supposed them to be cytosolic; in this 













Fig. 4. (a) Summary of the distribution of GDI and rab5 complexes 
in membranes and cytosol (see text for refs.). (b) Model for the regu- 
lation of rab protein association with membranes (see text for explana- 
tion). Complexes of GDI with rab protein which have not been de- 
tected, and correspond to the putattve intermediates, are shown in 
parenthesis. D, GDP-bound rab protein; E, exchange protein; GDI, 
guanme nucleotide dissociation inhibitor; P, phosphate; P,, inorganic 
phosphate; T, GTP-bound rab protein. 
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simply realised. In conclusion, our studies suggest that 
GDI serves as universal regulator of membrane trans- 
port, perhaps controlling both the specificity and the 
directionality of the rab protein cycling pathway. 
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